Industry

– Application is based on data from the Phase III STARGLO study where Columvi plus chemotherapy showed a statistically significant and clinically meaningful improvement in overall survival – – This regimen could provide an off-the-shelf, fixed-duration treatment option for patients to start soon after diagnosis, which is important for those who are at high-risk of … [Read more…]

This year’s winner: Entomal Biotech from Malaysia, offering biotech waste management solution that converts organic waste into insect protein and fertilizer Kisui TECH from Japan wins Kashiwa-no-ha Award and places third overall with its autonomous AI off-road platform supporting agriculture KASHIWA, Japan–(BUSINESS WIRE)–The Asian Entrepreneurship Award (AEA) Steering Committee is pleased to announce that AEA2024, … [Read more…]

(Securities Code: 4967 JT) * Oasis nominates three highly qualified, independent, diverse director candidates * Oasis nominates independent investigator to lead investigation into recent Beni-Koji scandal *Oasis urges Kobayashi Pharma shareholders to vote FOR Oasis’s proposals *Oasis calls for Kobayashi Pharma to transform its corporate governance to prevent the recurrence of a tragedy More information … [Read more…]

HORSHAM, Pa.–(BUSINESS WIRE)–NMS Labs announced today that David Delia has been selected as the new President and Chief Executive Officer of the Company. Mr. Delia will guide the organization’s growth while upholding our dedication to quality and service. Mr. Delia joined NMS Labs in 2016 as CFO overseeing several critical functions, including Finance, IT, Procurement, … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Breast Cancer Therapeutics – A Global Market Overview” report has been added to ResearchAndMarkets.com’s offering. This global report on Breast Cancer Therapeutics analyzes the market based on therapy type, cancer type, and distribution channels. In addition to providing profiles of major companies operating in this space, the latest corporate and industrial developments have … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Cancer Immunotherapy Drug Discovery Outsourcing – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering. The global market for Cancer Immunotherapy Drug Discovery Outsourcing was estimated at US$1.6 Billion in 2023 and is projected to reach US$4.0 Billion by 2030, growing at a CAGR of 13.7% from 2023 to 2030. This … [Read more…]

Preclinical data presented at Cell Symposia conference show a small molecule directed at a pathogenic RNA achieved reversal of myotonia in an animal model of myotonic dystrophy Type 1 (DM1) Supports additional product development with Company’s multi-modality rSM drug platform, broadening the reach of genetic medicine and offering the potential to treat diseases at their … [Read more…]

AUSTIN, Texas–(BUSINESS WIRE)–Owner Resource Group, LLC (“ORG”), an Austin, Texas-based private investment firm, is pleased to announce that ORG Opportunity Fund IV, LP, and its affiliates have completed an investment in Purpose Healing Center, LLC (“Purpose Healing” or the “Company”), a leading provider of behavioral health services. The Braff Group served as the exclusive financial … [Read more…]

The annual list recognizes the industry-leading companies that are the best at what they do SAN FRANCISCO–(BUSINESS WIRE)–Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, is proud to announce its inclusion on the Inc. 2024 Best in Business list in the Health Products category. Inc.’s annual Best … [Read more…]

Retail and Hospitality & Travel Leading in Automation, Healthcare and Transportation Falling Behind According to State of High-Volume Hiring: 2025 Benchmarks Report PHILADELPHIA–(BUSINESS WIRE)–#HRTech—Phenom today released its State of High-Volume Hiring: 2025 Benchmarks Report, which analyzed 101 companies on their maturity and use of artificial intelligence (AI) and automation technology to hire frontline, hourly, seasonal … [Read more…]